# ClinicalTrials.gov record NCT06872060

> PeptideScanner retained ClinicalTrials.gov record NCT06872060 at 2026-07-30T18:20:54.427Z. Its registry update date was 2025-10-03, and PeptideScanner's reviewed identity mapping was glucagon.

- Evidence object: `story:clinicaltrials-gov-nct06872060-glucagon:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-10-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06872060-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06872060-glucagon-v1.json
- Content SHA-256: `c81876f4a3e2059cf4769cc457f63226cebf1859cbdd3bf101cde34f2b42c5e3`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06872060 ([`ctg-observation-nct06872060-2025-10-03-9b63b07da934`](#source-ctg-observation-nct06872060-2025-10-03-9b63b07da934))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06872060 at 2026-07-30T18:20:54.427Z. Its registry update date was 2025-10-03, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct06872060-2025-10-03-9b63b07da934`](#source-ctg-observation-nct06872060-2025-10-03-9b63b07da934))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06872060 at 2026-07-30T18:20:54.427Z. Its registry update date was 2025-10-03, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct06872060-2025-10-03-9b63b07da934`](#source-ctg-observation-nct06872060-2025-10-03-9b63b07da934))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06872060-2025-10-03-9b63b07da934`](#source-ctg-observation-nct06872060-2025-10-03-9b63b07da934))

## Sources

<a id="source-ctg-observation-nct06872060-2025-10-03-9b63b07da934"></a>
- **ClinicalTrials.gov record NCT06872060 · retained source version 2025-10-03:9b63b07da93423220500278ec33e5b16fc191e42000d943e64c002c4ea259e0e** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06872060) (`ctg-observation-nct06872060-2025-10-03-9b63b07da934`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06872060." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06872060-glucagon-v1.json SHA-256: c81876f4a3e2059cf4769cc457f63226cebf1859cbdd3bf101cde34f2b42c5e3.